ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1–Infected, Antiretroviral Therapy–Naive Subjects

por Letendre, Scott L., Mills, Anthony M., Tashima, Karen T., Thomas, Deborah A., Min, Sherene S., Chen, Shuguang, Song, Ivy H., Piscitelli, Stephen C.
Publicado 2014

Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents

por Mills, Anthony M, Schulman, Kathy L, Fusco, Jennifer S, Wohlfeiler, Michael B, Priest, Julie L, Oglesby, Alan, Brunet, Laurence, Lackey, Philip C, Fusco, Gregory P
Publicado 2021

Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study

por Mills, Anthony M., Brunet, Laurence, Fusco, Jennifer S., Wohlfeiler, Michael B., Garris, Cindy P., Oglesby, Alan K., Mrus, Joseph M., Lackey, Philip C., Fusco, Gregory P.
Publicado 2019